Pain Management Devices Market By Type (Electrical Stimulators, TENS, Analgesic Pumps, Intrathecal Pumps, Radiofrequency Ablation Devices, Neurostimulators, Spinal Cord Stimulators, Sacral Nerve Stimulators, Deep Brain Stimulators And Others) For Cancer Pain, Neuropathic Pain, Facial & Migraine Pain, Musculoskeletal Pain And Other Application - Global Industry Perspective, Comprehensive Analysis, Size, Share, Growth, Segment, Trends, And Forecast, 2020 – 2028

Description

Market Overview     

The global Pain Management Devices market accounted for USD 4.26 Billion in 2020 and is expected to reach USD 6.70 Billion by 2028, growing at a CAGR of around 6.1% between 2021 and 2028.

The pain management devices market was likely to ascertain the very best development within the years to return due to advanced health care facilities and rise within the percentage of Cancer Pains everywhere in the world. Moreover, the increasing requirement for long-term pain management amongst the elderly population is probably going to spice up the demand for the global pain management devices market. Additionally to the present, the adverse impact of drugs paired with unpalatable taste is believed to be in charge of a serious development within the health care industry, which is predicted to flourish the worldwide pain management devices market. Aside from this, the introduction of various pain management devices will possibly elevate the need for pain management devices, thereby enacting the event of the worldwide pain management devices market.

On the opposite hand, the high price of pain management machines might act as a limitation for the event of worldwide pain management devices market. Increasing R&D is additionally one of the main factors that act as a catalyst for the event of worldwide pain management devices market. For instance, in April 2018, NeuroMetrix declared outcomes from clinical research of its Quell wearable device. It marketed the device’s capability to treat chronic pain. Outcomes from the study were reported within the Journal of Pain Research.

COVID-19 Impact Analysis  

Besides, the COVID-19 outbreak, there's a drastic rise in the demand for healthcare facilities across the world. The increasing corona cases across the world are forcing governments of developed and emerging countries to extend their patient handling capacities. However, nationwide lockdowns have impacted patients who specifically depend on PT or exercise programs as a pain management regimen. Also, many elective procedures, in-person patient visits have been canceled or rescheduled, which is anticipated to increase the demand for at-home pain treatment. 

Growth Factors

The increasing cases of chronic diseases are one of the key factors expected to contribute to the expansion of the market over the forecast period. The rising prevalence of lifestyle disorders, like obesity and diabetes, has increased the demand for muscle and nerve stimulators, thereby augmenting the market growth. The increasing cancer cases are expected to further increase product demand over the forecast period. Moreover, the high prevalence of musculoskeletal disorders, like arthritis, orthopedic degenerative disorders, osteoarthritis, and atrophic arthritis, and a resultant rise in cases of chronic pain and inability to hold out routine tasks, will boost product demand.

Report Scope:  

Application Segment Analysis Preview  

Based on application, the global pain management devices market is split into five types like neuropathic pain, cancer pain, musculoskeletal pain, facial & migraine pain, among others. In the application section, neuropathic pain was the dominating section in 2017. This neuropathic pain section was expected to ascertain the very best development within the years to return, majorly due to the high occurrence of diseases resulting in neuropathic pain. Almost over 70% of adults experience back pain, which comes below neuropathic pain. This development of the pain device management market is additionally mainly credited to the increase in the number of Cancer Pains paired with the increment within the number of doctors everywhere on the planet.

Product Segment Analysis Preview  

The neurostimulation segment held the most important revenue share of 57.5% in 2019. the expansion is often attributed to the increased prevalence of neurological disorders. These neurostimulators play an important role in treating chronic pain, Parkinson’s disease, epilepsy, movement disorders, and depression. additionally, certain factors like escalating product demand, the introduction of technologically advanced products, and therefore the growing geriatric population are anticipated to spice up the segment growth.

Regional Analysis Preview

Based on geography, North America was the dominant area for the global pain management devices market in 2017 in terms of income. This was owing to the expansion of novel pain management machines within the healthcare market, thereby boosting the worldwide pain management devices market.

The APAC market is estimated to grow at a promising CAGR during the forecast period. Factors like the increasing number of cancer patients, growth within the elderly population, healthcare infrastructure improvements, and therefore the increasing prevalence of chronic diseases are the main factors driving market growth within the Asia Pacific.

Key Market Players & Competitive Landscape

The major players that are comprised in  Pain Management Devices market are major players such as Boston Scientific Corporation, Baxter International Inc., Kimberly-Clark Corporation, DJO Global LLC, Medtronic, Inc., Smiths Medical, Codman And Shurtleff, Inc, St. Jude Medical, Inc., Hospira Inc., and Stryker Corporation.

The global  Pain Management Devices Market is segmented as follows:

By Type

• Electrical Stimulators
• TENS
• Analgesic Pumps
• Intrathecal Pumps
• Radiofrequency Ablation Devices
• Neurostimulators
• Spinal Cord Stimulators
• Sacral Nerve Stimulators
• Deep Brain Stimulators 
• Others 

By Application

• Cancer Pain
• Neuropathic Pain
• Facial & Migraine Pain
• Musculoskeletal Pain 
• Others 

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table Of Content

• Chapter No. 1 Introduction
  • 1.1. Report Description
    • 1.1.1. Purpose of the Report
    • 1.1.2. USP & Key Offerings
  • 1.2. Key Benefits for Stakehulders
  • 1.3. Target Audience
  • 1.4. Report Scope
• Chapter No. 2 Executive Summary
  • 2.1. Key Findings
    • 2.1.1. Top Investment Pockets
      • 2.1.1.1. Market Attractiveness Analysis, By Type
      • 2.1.1.2. Market Attractiveness Analysis, By Application
      • 2.1.1.3. Market Attractiveness Analysis, By Region
  • 2.2. Market Snapshot
  • 2.3. Global Pain Management Devices Market, 2016 – 2028 (USD Billion)
  • 2.4. Insights from Primary Respondents
• Chapter No. 3 COVID 19 Impact Analysis
  • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
    • 3.1.1. North America
    • 3.1.2. Europe
    • 3.1.3. Asia Pacific
    • 3.1.4. Latin America
    • 3.1.5. The Middle-East and Africa
  • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
  • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
  • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
  • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
    • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
  • 3.6. Short Term Dynamics
  • 3.7. Long Term Dynamics
• Chapter No. 4 Pain Management Devices Market – Product Segment Analysis
  • 4.1. Overview
    • 4.1.1. Market Revenue Share, By Type, 2020 & 2028
  • 4.2. Electrical Stimulators
    • 4.2.1. Market Size and Forecast, By Region (USD Billion)
    • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.3. TENS
    • 4.3.1. Market Size and Forecast, By Region (USD Billion)
    • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.4. Analgesic Pumps
    • 4.4.1. Market Size and Forecast, By Region (USD Billion)
    • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.5. Intrathecal Pumps
    • 4.5.1. Market Size and Forecast, By Region (USD Billion)
    • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.6. Radiofrequency Ablation Devices
    • 4.6.1. Market Size and Forecast, By Region (USD Billion)
    • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.7. Neurostimulators
    • 4.7.1. Market Size and Forecast, By Region (USD Billion)
    • 4.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.7.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.8. Spinal Cord Stimulators
    • 4.8.1. Market Size and Forecast, By Region (USD Billion)
    • 4.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.8.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.9. Sacral Nerve Stimulators
    • 4.9.1. Market Size and Forecast, By Region (USD Billion)
    • 4.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.9.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.10. Deep Brain Stimulators
    • 4.10.1. Market Size and Forecast, By Region (USD Billion)
    • 4.10.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.10.3. Key Market Trends, Growth Factors, & Opportunities
  • 4.11. Others
    • 4.11.1. Market Size and Forecast, By Region (USD Billion)
    • 4.11.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 4.11.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 5 Pain Management Devices Market – End User Segment Analysis
  • 5.1. Overview
    • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
  • 5.2. Cancer Pain
    • 5.2.1. Market Size and Forecast, By Region (USD Billion)
    • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.3. Neuropathic Pain
    • 5.3.1. Market Size and Forecast, By Region (USD Billion)
    • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.4. Facial & Migraine Pain
    • 5.4.1. Market Size and Forecast, By Region (USD Billion)
    • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.5. Musculoskeletal Pain
    • 5.5.1. Market Size and Forecast, By Region (USD Billion)
    • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
  • 5.6. Others
    • 5.6.1. Market Size and Forecast, By Region (USD Billion)
    • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
    • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
• Chapter No. 6 Plant Factory Grow Market – Region Segment Analysis
  • 6.1. Overview
    • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
    • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
  • 6.2. North America
    • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
    • 6.2.2. North America Market Revenue, By Type, 2016 – 2028
    • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Type, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
  • 6.2.6. Canada
    • 6.2.6.1. Canada Market Revenue, By Type, 2016 – 2028
    • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
  • 6.2.7. Mexico
    • 6.2.7.1. Mexico Market Revenue, By Type, 2016 – 2028
    • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
• 6.3. Europe
  • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
  • 6.3.2. Europe Market Revenue, By Type, 2016 – 2028
  • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
  • 6.3.5. Germany
    • 6.3.5.1. Germany Market Revenue, By Type, 2016 – 2028
    • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
  • 6.3.6. France
    • 6.3.6.1. France Market Revenue, By Type, 2016 – 2028
    • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
  • 6.3.7. U.K.
    • 6.3.7.1. U.K. Market Revenue, By Type, 2016 – 2028
    • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
  • 6.3.8. Italy
    • 6.3.8.1. Italy Market Revenue, By Type, 2016 – 2028
    • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
  • 6.3.9. Spain
    • 6.3.9.1. Spain Market Revenue, By Type, 2016 – 2028
    • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
  • 6.3.10. Rest of Europe
    • 6.3.10.1. Rest of Europe Market Revenue, By Type, 2016 – 2028
    • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
• 6.4. Asia Pacific
  • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
  • 6.4.2. Asia Pacific Market Revenue, By Type, 2016 – 2028
  • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
  • 6.4.5. China
    • 6.4.5.1. China Market Revenue, By Type, 2016 – 2028
    • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
  • 6.4.6. Japan
    • 6.4.6.1. Japan Market Revenue, By Type, 2016 – 2028
    • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
  • 6.4.7. India
    • 6.4.7.1. India Market Revenue, By Type, 2016 – 2028
    • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
  • 6.4.8. South Korea
    • 6.4.8.1. South Korea Market Revenue, By Type, 2016 – 2028
    • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
  • 6.4.9. South-East Asia
    • 6.4.9.1. South-East Asia Market Revenue, By Type, 2016 – 2028
    • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
  • 6.4.10. Rest of Asia Pacific
    • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Type, 2016 – 2028
    • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
• 6.5. Latin America
  • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
  • 6.5.2. Latin America Market Revenue, By Type, 2016 – 2028
  • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
  • 6.5.5. Brazil
    • 6.5.5.1. Brazil Market Revenue, By Type, 2016 – 2028
    • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
  • 6.5.6. Argentina
    • 6.5.6.1. Argentina Market Revenue, By Type, 2016 – 2028
    • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
  • 6.5.7. Rest of Latin America
    • 6.5.7.1. Rest of Latin America Market Revenue, By Type, 2016 – 2028
    • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
• 6.6. The Middle-East and Africa
  • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
  • 6.6.2. The Middle-East and Africa Market Revenue, By Type, 2016 – 2028
  • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
  • 6.6.5. GCC Countries
    • 6.6.5.1. GCC Countries Market Revenue, By Type, 2016 – 2028
    • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
  • 6.6.6. South Africa
    • 6.6.6.1. South Africa Market Revenue, By Type, 2016 – 2028
    • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
  • 6.6.7. Rest of Middle-East Africa
    • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Type, 2016 – 2028
    • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028

• Chapter No. 7: Pain Management Devices Market – Industry Analysis
  • 7.1. Introduction
  • 7.2. Market Drivers
    • 7.2.1. Driving Factor 1 Analysis
    • 7.2.2. Driving Factor 2 Analysis
  • 7.3. Market Restraints
    • 7.3.1. Restraining Factor Analysis
  • 7.4. Market Opportunities
    • 7.4.1. Market Opportunity Analysis
  • 7.5. Porter’s Five Forces Analysis
  • 7.6. PEST Analysis
  • 7.7. Regulatory Landscape
  • 7.8. By Application Landscape
  • 7.9. Regional Market Trends
    • 7.9.1. North America
    • 7.9.2. Europe
    • 7.9.3. Asia Pacific
    • 7.9.4. Latin America
    • 7.9.5. The Middle-East and Africa
  • 7.10. Pricing Analysis
  • 7.11. Value Chain Analysis
  • 7.12. Downstream Buyers
  • 7.13. Distributors/Traders List
• Chapter No. 8: Competitive Landscape
  • 8.1. Company Market Share Analysis – 2019
    • 8.1.1. Global Pain Management Devices Market: Company Market Share, 2019
    • 8.1.2. Global Pain Management Devices Market, Company Market Revenue, 2016 – 2019 (USD Billion)
    • 8.1.3. Global Pain Management Devices Market, Company Y-o-Y Growth, 2017 – 2019 (%)
    • 8.1.4. Global Pain Management Devices Market: Radar Determinant Chart, 2019
  • 8.2. Strategic Developments
    • 8.2.1. Acquisitions & Mergers
    • 8.2.2. New Product Launch
    • 8.2.3. Regional Expansion
  • 8.3. Company Strategic Developments – Heat Map Analysis
• Chapter No. 9: Company Profiles
  • 9.1. Smiths Medical
    • 9.1.1. Company Overview
    • 9.1.2. Key Executives
    • 9.1.3. Product Portfulio
    • 9.1.4. Financial Overview
    • 9.1.5. Operating Business Segments
    • 9.1.6. Business Performance
    • 9.1.7. Recent Developments
  • 9.2. Stryker Corporation
  • 9.3 B. Braun Melsungen AG
  • 9.4 Baxter
  • 9.5 Boston Scientific Corp.
  • 9.6 Culfax Corp.
  • 9.7 Medtronic Plc
  • 9.8 Nevro Corp.
  • 9.9 Abbott
  • 9.10 Omron Healthcare, Inc.
• Chapter No. 10: Marketing Strategy Analysis
  • 10.1. Marketing Channel
  • 10.2. Direct Marketing
  • 10.3. Indirect Marketing
  • 10.4. Marketing Channel Development Trends
  • 10.5. Economic/Pulitical Environmental Change
• Chapter No. 11: Research Methodulogy
  • 11.1. Research Methodulogy
  • 11.2. Phase I - Secondary Research
  • 11.3. Phase II - Data Modeling
    • 11.3.1. Company Share Analysis Model
    • 11.3.2. Revenue Based Modeling
  • 11.4. Phase III - Primary Research
  • 11.5. Research Limitations
    • 11.5.1. Assumptions

Methodology

This report is based on in-depth qualitative and quantitative analyses of the global Pain Management Devices market. Zion Research has collected and analyzed key data belong to the global Pain Management Devices market using a variety of methods. Quantitative analysis has been done following various projection and sampling techniques.

The qualitative analysis involved primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes were validated through experts' opinions. The market dynamics have been determined afterconducting a detailed study of the micro and macroeconomic indicators of the market.

Various parameters have been taken into account, while estimating market size. The revenue generated by the leading industry participants in from the sales of Pain Management Devices across the world has been calculated through primary and secondary research.

Zion Research employs combination of secondary research followed by extensive primary research. Under secondary research, we refer to prominent paid as well as open access data sources including product literature, company annual reports, government publications, press releases, industry association’s magazines and other relevant sources for data collection. Other prominent secondary sources include, STATISTA, trade journals, trade associations, statistical data from government websites, etc. 

For this study, Zion Research has conducted all-encompassing primary research with key industry participants to collect first had data. Moreover, in-depth interviews with key opinion leaders also assistedin validation of findings from secondary research and to understand key trends in the Pain Management Devices industry. Primary research makes up major source of data collection and validation.   

Primary Research

We conduct primary interviews with industry participants and commentators on an ongoing basis to validate data and analysis. A typical research interview fulfills the following functions:

• Provides firsthand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
• Helps in validating and strengthening the secondary research findings
• Further develops the analysis team’s expertise and market understanding
• Primary research involves e-mail interactions, telephonic interviews as well as face-to-face interviews for each market, category, segment and sub-segment across geographies

Participants who typically participate in such a process include, but are not limited to:

• Industry participants: CEOs, VPs, marketing/product managers, market intelligence managers and national sales managers
• Purchasing managers, technical personnel, distributors and resellers
• Outside experts: Investment bankers, valuation experts and research analysts specializing in specific markets

Key opinion leaders specializing in different areas corresponding to different industry verticals

Secondary Research

Secondary research sources that are typically referred to include, but are not limited to:

• Company websites, annual reports, financial reports, broker reports, investor presentations and SEC filings
• IDC and other relevant magazines
• Internal and external proprietary databases, and relevant patent and regulatory databases
• National government documents, statistical databases and market reports

News articles, press releases and webcasts specific to companies operating in the market

Following a comprehensive secondary and primary research and insights thus gathered, analysts at Zion Research have provided an in-depth analysis of various aspects of the Pain Management Devices market.

Models

Where no hard data is available, we use models and estimates to produce comprehensive data sets. A rigorous methodology is adopted, wherein the available hard data is cross-referenced with the following data types to produce estimates:

• Demographic data: Population split by segments
• Macroeconomic indicators: GDP, PPP, Per Capita Income, etc.
• Industry indicators: Expenditure, technology stage and infrastructure, sector growth and facilities
• Data is then cross-checked by an expert panel.

Free Analysis

Pain is a stressful feeling mainly caused by intense or damaging stimuli. Pain management devices are the electrical or non electrical devices used to deal with severe and acute pain management in patients who are suffering from various medical conditions. Various pains include cancer pain, neurological disorders, and musculoskeletal disorders. The pain management devices help to restore the ability of patients to do everyday activities, decrease the need for oral pain medications, and improve the quality of life of patients suffering from these conditions.

Globally, pain management device market has been accelerated by increasing awareness for controlling the pain caused by various medical conditions like cancer pain, neuropathic pain and chemical pain. Moreover, growing number of surgical procedures, healthcare expenditure is directly responsible for fueling the growth of pain management device market. Furthermore, large population base and rapid economic development in some developing countries is expected to improve access to quality healthcare which drive the growth of pain management device market. However, high procedural and purchase cost of pain management devices are considered as a restraint for the growth of pain management device market. Nonetheless, untapped market is considered as major opportunity for the growth of global pain management device market.

Based on type, the global market of pain management device is bifurcated into nine types: electrical stimulators, TENS, analgesic pumps, intrathecal pumps, radio-frequency ablation devices, neurostimulators, spinal cord stimulators, sacral nerve stimulators, deep brain stimulators and others. Electrical stimulation device dominates the global electrical stimulation devices market and was projected to expand approximately at a CAGR of 5.8% from 2016 to 2021. This growth is attributed to in going research and development in electrical stimulation device market.

Based on application, the global market of pain management device is bifurcated into five types: cancer pain, neuropathic pain, facial & migraine pain, musculoskeletal pain and others. The neuropathic pain segment was the leading segment in 2015. This neuropathic pain segment is estimated to witness the highest growth during the forecast period, primarily due to the high prevalence of diseases resulting in neuropathic pain followed by other pain. Other factors that propels the growth of these segments includes global rise in hospitals and healthcare center. However, other applications like pregnancy/labor and menstrual pain, sports injuries, post-operative pain, and trauma pain is expected to fuel the growth of pain management device market, which accounted for approximately above 15% of market share in 2015.

Based on geographies, the global market of pain management devices market is bifurcated into five types: North America, Europe, Asia Pacific, Latin America and Middle East and Africa. These segments are further bifurcated into UK, Germany, France, China, Japan, India and Brazil. North America accounted for the largest share of the global pain management devices market, followed by Europe. Global pain management device market was dominated by North America in 2015 in term of revenue followed by Europe. This growth is attributed due to rising awareness related to health care in this region. Moreover, pain management devices market has huge opportunity in the emerging markets of Asia Pacific due to increasing standard of living, large patient base in this region. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period, due to the rising incidence of chronic diseases, increasing government support, and growing middle-class population and rise in disposable income levels in this region. Emerging economy like Brazil is expected to fuel the growth in Latin America region.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global pain management devices market including Baxter International Inc., Boston Scientific Corporation, DJO Global LLC, Kimberly-Clark Corporation, Smiths Medical, Medtronic, Inc., St. Jude Medical, Inc., Codman And Shurtleff, Inc, Stryker Corporation and Hospira Inc.